New Investment Models in Health-Related R&D – the Case of Antibiotic Resistance
5 Oct 2017
Investment in new classes of antibiotics and better stewardship programmes for existingantibiotics would be crucial to ward off the risks from antibiotic drugresistance, said James Zhan, UNCTAD Director of Investment and Enterprise.
Connect with us